130 related articles for article (PubMed ID: 23727622)
1. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
4. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
5. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
[TBL] [Abstract][Full Text] [Related]
6. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
[TBL] [Abstract][Full Text] [Related]
7. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
[TBL] [Abstract][Full Text] [Related]
8. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
9. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
10. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma.
Huang CY; Pu YS; Shiue HS; Chen WJ; Lin YC; Hsueh YM
Arch Toxicol; 2016 Aug; 90(8):1917-27. PubMed ID: 26359225
[TBL] [Abstract][Full Text] [Related]
13. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
14. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
15. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.
Leibovici D; Grossman HB; Dinney CP; Millikan RE; Lerner S; Wang Y; Gu J; Dong Q; Wu X
J Clin Oncol; 2005 Aug; 23(24):5746-56. PubMed ID: 16110031
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure.
Yang TY; Hsu LI; Chiu AW; Pu YS; Wang SH; Liao YT; Wu MM; Wang YH; Chang CH; Lee TC; Chen CJ
Environ Res; 2014 Jan; 128():57-63. PubMed ID: 24268366
[TBL] [Abstract][Full Text] [Related]
18. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
19. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
20. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.
Hsu LI; Chiu AW; Huan SK; Chen CL; Wang YH; Hsieh FI; Chou WL; Wang LH; Chen CJ
Toxicol Appl Pharmacol; 2008 Apr; 228(2):144-55. PubMed ID: 18199464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]